Literature DB >> 1095681

The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen.

F Melchers, V Braun, C Galanos.   

Abstract

The lipoprotein of the outer membrane of Escherichia coli is a B-cell mitogen in mice. Polyclonal activation of B lymphocytes was measured by an increase in thymidine uptake, by the development of plaque-forming cells against densely coupled trinitrophenylated sheep red cells, and by selectively increased rates of synthesis and secretion of leucine-labeled IgM. Murein-free and muropeptides-containing lipoprotein are effective in B-cell activation, while free murein is inactive. Removal of ester-linked fatty acids from the amino-terminal end of the lipoprotein by alkaline hydrolysis abolishes the mitogenicity of the lipoprotein. B lymphocytes from high responder (C3H/Tif and BALB/c nu/nu) or from low responder (C3H/HeJ) mice to the mitogen lipopolysaccharide (LPS) both respond well to the lipoprotein. Anti-immunoglobulin antibodies inhibit the mitogenic stimulation of B cells by lipoprotein. A complex of structures including the Ig-receptor molecules, the LPS receptor, and the lipoprotein receptor appear involved in the regulation of mitogenic stimulation of B cells to proliferation and differentiation to IgM-secreting cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095681      PMCID: PMC2189908          DOI: 10.1084/jem.142.2.473

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Composition of the cell wall of Staphylococcus aureus: its relation to the mechanism of action of penicillin.

Authors:  J L STROMINGER; J T PARK; R E THOMPSON
Journal:  J Biol Chem       Date:  1959-12       Impact factor: 5.157

2.  [Effect of cortisone on experimental Salmonella typhi infection in the mouse].

Authors:  L CHEDID; F BOYER; M SAVIARD
Journal:  C R Hebd Seances Acad Sci       Date:  1951-09-24

3.  "Spontaneous" B cell activation due to loss of normal mouse serum suppressor.

Authors:  W W Bullock; E Möller
Journal:  Eur J Immunol       Date:  1972-12       Impact factor: 5.532

Review 4.  Biochemistry of bacterial cell envelopes.

Authors:  V Braun; K Hantke
Journal:  Annu Rev Biochem       Date:  1974       Impact factor: 23.643

5.  Supramolecular structure of the rigid layer of the cell wall of Salmonella, Serratia, Proteus, and Pseudomonas fluorescens. Number of lipoprotein molecules in a membrane layer.

Authors:  V Braun; K Rehn; H Wolff
Journal:  Biochemistry       Date:  1970-12-22       Impact factor: 3.162

6.  PPD tuberculin--a B-cell mitogen.

Authors:  B M Sultzer; B S Nilsson
Journal:  Nat New Biol       Date:  1972-12-13

7.  Structural relationship of Salmonella O and R antigens.

Authors:  O Lüderitz; C Galanos; H J Risse; E Ruschmann; S Schlecht; G Schmidt; H Schulte-Holthausen; R Wheat; O Westphal; J Schlosshardt
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

8.  Repetitive sequences in the murein-lipoprotein of the cell wall of Escherichia coli.

Authors:  V Braun; V Bosch
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

9.  Purified protein derivative of tuberculin induces immunoglobulin production in normal mouse spleen cells.

Authors:  B S Nilsson; B M Sultzer; W W Bullock
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

10.  Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  81 in total

1.  Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.

Authors:  J Hellman; P M Loiselle; M M Tehan; J E Allaire; L A Boyle; J T Kurnick; D M Andrews; K Sik Kim; H S Warren
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect.

Authors:  Avi-Hai Hovav; Liuba Davidovitch; Gabriel Nussbaum; Jacob Mullerad; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

4.  Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators.

Authors:  W G Bessler; B Kleine; C Martinez Alonso; L Biesert; M Strecker; K H Wiesmüller; J Metzger; G Jung
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  Characterization of the chemical and physical properties of a novel B-lymphocyte activator, endotoxin protein.

Authors:  G W Goodman; B M Sultzer
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

7.  Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection.

Authors:  N von Jeney; E Günther; K Jann
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  Studies on the mechanism of peptidoglycan- and lipopolysaccharide-induced polyclonal activation.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

9.  Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

10.  Isolation and characterization of an outer membrane protein of Salmonella paratyphi B: a mitogen and polyclonal activator of human B lymphocytes.

Authors:  S Sager; G Virella; W Y Chen; H H Fudenberg
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.